Target intelligence / Profile preview

Microtubule protein beta-tubulin (β-tubulin)

Target
β-tubulin
Molecular classification
Structural protein, Cytoskeletal protein, Tubulin family protein, Other
01

Overview

Microtubule protein beta-tubulin is one of the main protein subunits (alongside alpha-tubulin) forming microtubules, hollow tubular structures essential for cell division, intracellular transport, and maintenance of cell shape. β-tubulin has a compact molecular structure and binds guanine nucleotides and multiple drugs at distinct functional domains. As a critical cytoskeletal protein, β-tubulin is targeted by many chemotherapy drugs to disrupt cell division, especially in cancer. The protein is encoded by several genes, resulting in isotypes that play roles not only in normal physiology but also in diseases such as cancer, neurodegenerative disorders, and tubulinopathies.

Other names
Tubulin, betaTUBB (gene name)Tubulin beta chainBeta-tubulin
02

Mechanism of action

Stabilization of microtubules (e.g., paclitaxel, docetaxel); Depolymerization or destabilization of microtubules (e.g., vincristine, vinblastine, colchicine, benomyl); Inhibition of microtubule dynamics → disruption of mitosis/cell division and induction of cell death

03

Biological functions

Cell division (mitosis and meiosis)Structural supportIntracellular transportPathway for motor proteins (e.g., kinesin, dynein)Regulation of cell shape and polarityCell cycle progression
04

Disease associations

Cancer (drug target and mutations in tubulin genes)Neurodegenerative disease (tubulinopathies, Alzheimer’s disease)Inflammation (involvement in immune cell activation)Other (e.g., drug resistance in tumors)
05

Safety considerations

Neuropathy (dose-dependent, from microtubule-targeting agents)MyelosuppressionDrug resistance (mutations or altered expression of tubulin isotypes)Off-target cytotoxicity (affects dividing non-cancer cells, such as bone marrow and gastrointestinal lining)
06

Interacting drugs

Paclitaxel (Taxol)

5 more in the full profile.

07

Biomarkers

β-tubulin isotype expression (eg, βIII-tubulin as marker for chemotherapy response in cancer)Tubulin mutations (in tubulinopathies and resistance to drugs)Tubulin post-translational modifications (as potential disease markers)

Beyond the preview

Go deeper on Microtubule protein beta-tubulin (β-tubulin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule protein beta-tubulin (β-tubulin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call